Exostar, a cloud-based solutions company, has partnered with Veeva Systems, a cloud-based software provider for the global life sciences industry. Veeva Vault, a content management platform and suite of applications that reduces IT complexity and increases business agility, now can be accessed through Exostar’s Life Sciences Identity Hub. The connection enables life sciences organizations and their partners to prepare, exchange and store clinical trials documentation with the ease and security of a single credential.

Exostar and Veeva are working together to streamline the provisioning process of creating Vault accounts with appropriate roles and permissions for all individuals participating in a clinical trial, regardless of their affiliation. Exostar’s Secure Access Manager (SAM) delivers an added layer of security when authenticating individuals. With SAM credentials, individuals enjoy a single sign-on experience to Vault and other applications connected to the Life Sciences Identity Hub. The credentials also support the inclusion of validated electronic signatures as documents are shared in Vault throughout clinical trials workflow processes.

“Bringing Vault and SAM together allows clinical trials personnel throughout our life sciences community to fully benefit from the strengths of both solutions in a seamlessly integrated environment,” said Exostar Vice President of Security and Collaboration Solutions Vijay Takanti. “Vault enables global business processes and serves as a single source of truth for content, while SAM provides the access control and document signature security necessary for information protection and compliance.”

Veeva Vault is the first cloud platform built specifically to meet the rigorous requirements for content management in the life sciences industry. The Vault eTMF application offers full Trial Master File (TMF) Reference Model support. Clinical trial sponsors and their partners can establish and demonstrate control over document processes, using real-time dashboards and reporting to obtain visibility into document status and process bottlenecks. Sponsors can oversee trials more effectively, CROs can more efficiently manage the eTMF, sites can focus on research and auditors and inspectors get easy online access.